Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
about
Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.[Medication treatment of rheumatoid arthritis with a history of malignancy. Epidemiological data].Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisInflammatory bowel disease cause-specific mortality: a primer for cliniciansEffect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, MinnesotaChallenges in designing a national surveillance program for inflammatory bowel disease in the United States.Risk of Malignant Neoplasm in Patients with Incident Rheumatoid Arthritis 1980-2007 in relation to a Comparator Cohort: A Population-Based StudyComorbidities in Patients with Psoriatic Arthritis.Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor.Infectious and malignant complications of TNF inhibitor therapy in IBD.Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature.Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.The future of population-based postmarket drug risk assessment: a regulator's perspective.Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.Psoriasis in Solid Organ Transplant Patients: Best Practice Recommendations from the Medical Board of the National Psoriasis Foundation.Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors.The landscape of comparative effectiveness research in rheumatology.
P2860
Q30811500-A19717B2-C647-4148-B0D9-3F40D5DB03EEQ31036951-3DC16387-C5CF-46D1-BCE4-E11368C76840Q31041008-1E1F495D-BC51-4C7C-A1D0-D0225D482DCDQ33731716-7E1EBAB9-AFD3-406E-809B-51BC34A55825Q34570452-3660E96D-72D1-4958-B1E4-C23FD531C422Q35690314-9AE46DE1-8774-4B1F-B5D7-90619B0965EFQ36174814-C0851BA9-AFC6-4B25-BEFD-F358A43C4918Q37218755-E42479C8-7C74-4D4D-A53A-D2D92EB2E4E2Q37632137-767D0C9A-B578-47BE-9135-E5A64BCB3AE3Q37656273-8D9BA641-E1B9-450D-A80C-94EF00919EA2Q38138343-FDE4ED76-66FB-4221-BDC2-3EC099367ADFQ38176745-37FED86C-E653-4C35-9550-ABFB6C506212Q38681514-980C8B05-1E55-4474-9085-5119AB1CB68DQ38827889-F80139E2-6178-498C-9651-C9F4653FCCBFQ39406884-3265FD44-1D8E-4138-B23C-BD6B323D5F69Q39783472-975E464C-8521-4BAB-A906-EB4F0909D670Q39793022-46EF02D0-4172-4B32-B919-40FEF3221506Q40060986-5C5B4558-D33B-4659-AAE4-8303C667DE33Q40383687-32E982C1-D395-46F4-B49A-F5062D720C3DQ50027874-48BB1ECB-1525-4038-8180-79B2BDC0EFF8Q53126847-05EA2760-27DF-400A-B574-D1241E63EEA6
P2860
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor necrosis factor α inhibi ...... ronic immune-mediated diseases
@en
Tumor necrosis factor α inhibi ...... onic immune-mediated diseases.
@nl
type
label
Tumor necrosis factor α inhibi ...... ronic immune-mediated diseases
@en
Tumor necrosis factor α inhibi ...... onic immune-mediated diseases.
@nl
prefLabel
Tumor necrosis factor α inhibi ...... ronic immune-mediated diseases
@en
Tumor necrosis factor α inhibi ...... onic immune-mediated diseases.
@nl
P2093
P2860
P356
P1476
Tumor necrosis factor α inhibi ...... ronic immune-mediated diseases
@en
P2093
Craig Newcomb
Daniel H Solomon
David J Graham
James D Lewis
Jeffrey R Curtis
Kenneth G Saag
Kevin Haynes
Lisa J Herrinton
P2860
P356
10.1002/ART.37740
P577
2013-01-01T00:00:00Z